Friess Associates’s Inogen INGN Stock Holding History

Friess Associates’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-22,000	Closed	-$690K	–	162
2014 Q4	$690K	Hold	22,000	–	–	0.06%	92
2014 Q3	$453K	Buy	+22,000	New	+$447K	0.04%	95

Other funds holding INGN

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

TCM

Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Friess Associates's INGN Position: Q1 2015 in Review

Friess Associates sold out of Inogen (INGN) in Q1 2015, closing a stake of 22,000 shares — an estimated $690K sold.

Friess Associates first reported a position in INGN in Q3 2014 and held it in 2 quarters. The position peaked at $690K in Q4 2014. 108 funds tracked by Wall St. Rank hold INGN as of Q1 2015.

Friess Associates reported no remaining Inogen position as of Q1 2015 after selling out during the quarter.
Friess Associates sold 22,000 Inogen shares in Q1 2015, an estimated $690K.
Friess Associates first reported a position in Inogen in Q3 2014 and held it in 2 quarters.
Friess Associates's Inogen position peaked at $690K in Q4 2014.
108 funds tracked by Wall St. Rank held Inogen as of Q1 2015.

Based on Friess Associates's 13F filing for Q1 2015, filed 15 May 2015.